Fat Liver Disease: Blood Markers and Liver Scarring Study
Part of Digestive system clinical trials.
This study looks at whether certain blood markers—including inflammation and fat levels—can help predict scarring in fatty livers. Understanding this connection may help doctors better identify patients at risk for serious liver damage.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have recent fasting blood tests showing triglycerides, glucose, and inflammation markers
- You have had a FibroScan (a ultrasound-based test that measures liver stiffness) and a scan showing liver fat
- You don't drink alcohol in excess amounts
- You don't have viral hepatitis (hepatitis B or C) or other chronic liver diseases
- You are not currently pregnant
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at existing health survey data to see whether a specific immune-cell marker (called HsCAR) is related to fatty liver disease and liver scarring. It may help researchers better understand which people are at higher risk for worsening liver damage.
This study tests how well primary care doctors can screen for advanced liver scarring in people with fatty liver from non-alcohol causes or from alcohol use. It may help find liver problems earlier so you can get the right follow-up.
This study looks at special markers in the blood to better understand and predict a fatty liver condition called NAFLD. It focuses on people who are very overweight and are already planning to have weight-loss surgery.
This study is looking for new ways to detect liver scarring (fibrosis) in people with fatty liver disease (NAFLD, NASH, MASLD, or MASH). If you qualify, you will give a blood sample to help identify biomarkers that could replace biopsies.
This study tests a way to find liver scarring (fibrosis) early in people who have risk factors like being overweight, having type 2 diabetes, or drinking alcohol heavily. Early detection may help prevent serious liver damage.
This trial looks for better ways to detect liver scarring (fibrosis) in people with long-term liver disease. It may help find problems earlier.
Hear when a new Liver Fibrosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.